While“healthy” microbiome remains to be defined, microbiome disruption is associated with numerous diseases, offering new therapeutic opportunities if causalities are demonstrated. Europe is at the forefront of the understanding of the Microbiome and is well placed […]
The list of presentations from any recent microbiome conference shows the diversity of approaches by which scientists are pursuing discovery of microbiome-focused therapeutics. And common to all of these approaches is the essential need to […]
The Pharmabiotic Research Institute (PRI), a non-for-profit pro industry group that assists its members with the development of their Microbiotic Medicinal Products (MMPs) is hosting an ‘/OMICS’ Task Group March 14th in Paris, following Pharmabiotics 2019 Conference […]
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a Japanese dairy product company, today announced new research showing that consumption of its proprietary probiotic Morinaga Bifidobacterium infantis M-63 improved the mental state of victims of the disastrous 2014-2015 […]
4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]
Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced that enrollment has been completed for the first human safety study of AZT-04. AZT-04 is the Company’s lead product […]
Microbiome discovery platform company Eagle Genomics announces funding of $3.5M led by the Environmental Technologies Fund (ETF Partners), a European growth fund specialising in promoting sustainability through innovation. The raise will accelerate the development of […]
4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]
Evelo Biosciences, Inc.(Nasdaq: EVLO) (“Evelo”), a biotechnology company developing monoclonal microbials, a new modality of oral biologic medicines, announced that the University of Chicago has dosed the first patient in an investigator-sponsored Phase 2a clinical […]
Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating SGM-1019 for […]
One month short of its official 145th anniversary, global bioscience company Chr. Hansen is ranked the most sustainable company in the world by Corporate Knights, a specialized Toronto-based media and investment research firm. This was […]